These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 20920668)

  • 1. Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.
    McLaughlin HM; Sakaguchi R; Liu C; Igarashi T; Pehlivan D; Chu K; Iyer R; Cruz P; Cherukuri PF; Hansen NF; Mullikin JC; ; Biesecker LG; Wilson TE; Ionasescu V; Nicholson G; Searby C; Talbot K; Vance JM; Züchner S; Szigeti K; Lupski JR; Hou YM; Green ED; Antonellis A
    Am J Hum Genet; 2010 Oct; 87(4):560-6. PubMed ID: 20920668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).
    McLaughlin HM; Sakaguchi R; Giblin W; ; Wilson TE; Biesecker L; Lupski JR; Talbot K; Vance JM; Züchner S; Lee YC; Kennerson M; Hou YM; Nicholson G; Antonellis A
    Hum Mutat; 2012 Jan; 33(1):244-53. PubMed ID: 22009580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila.
    Ermanoska B; Motley WW; Leitão-Gonçalves R; Asselbergh B; Lee LH; De Rijk P; Sleegers K; Ooms T; Godenschwege TA; Timmerman V; Fischbeck KH; Jordanova A
    Neurobiol Dis; 2014 Aug; 68():180-9. PubMed ID: 24807208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
    Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A
    Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations.
    Wallen RC; Antonellis A
    Curr Opin Genet Dev; 2013 Jun; 23(3):302-9. PubMed ID: 23465884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathy-associated histidyl-tRNA synthetase variants attenuate protein synthesis in vitro and disrupt axon outgrowth in developing zebrafish.
    Mullen P; Abbott JA; Wellman T; Aktar M; Fjeld C; Demeler B; Ebert AM; Francklyn CS
    FEBS J; 2021 Jan; 288(1):142-159. PubMed ID: 32543048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tRNA synthetases in neurological and neuromuscular disorders.
    Boczonadi V; Jennings MJ; Horvath R
    FEBS Lett; 2018 Mar; 592(5):703-717. PubMed ID: 29288497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous Seryl-tRNA Synthetase 1 Variants Cause Charcot-Marie-Tooth Disease.
    He J; Liu XX; Ma MM; Lin JJ; Fu J; Chen YK; Xu GR; Xu LQ; Fu ZF; Xu D; Chen WF; Cao CY; Shi Y; Zeng YH; Zhang J; Chen XC; Zhang RX; Wang N; Kennerson M; Fan DS; Chen WJ
    Ann Neurol; 2023 Feb; 93(2):244-256. PubMed ID: 36088542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A missense, loss-of-function
    Forrest ME; Meyer AP; Laureano Figueroa SM; Antonellis A
    Cold Spring Harb Mol Case Stud; 2022 Dec; 8(7):. PubMed ID: 36307205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants of aminoacyl-tRNA synthetase genes in Charcot-Marie-Tooth disease: A Korean cohort study.
    Nam DE; Park JH; Park CE; Jung NY; Nam SH; Kwon HM; Kim HS; Kim SB; Son WS; Choi BO; Chung KW
    J Peripher Nerv Syst; 2022 Mar; 27(1):38-49. PubMed ID: 34813128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MARS variant associated with both recessive interstitial lung and liver disease and dominant Charcot-Marie-Tooth disease.
    Rips J; Meyer-Schuman R; Breuer O; Tsabari R; Shaag A; Revel-Vilk S; Reif S; Elpeleg O; Antonellis A; Harel T
    Eur J Med Genet; 2018 Oct; 61(10):616-620. PubMed ID: 29655802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.
    Kuo ME; Theil AF; Kievit A; Malicdan MC; Introne WJ; Christian T; Verheijen FW; Smith DEC; Mendes MI; Hussaarts-Odijk L; van der Meijden E; van Slegtenhorst M; Wilke M; Vermeulen W; Raams A; Groden C; Shimada S; Meyer-Schuman R; Hou YM; Gahl WA; Antonellis A; Salomons GS; Mancini GMS
    Am J Hum Genet; 2019 Mar; 104(3):520-529. PubMed ID: 30824121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
    Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
    Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital Visual Impairment and Progressive Microcephaly Due to Lysyl-Transfer Ribonucleic Acid (RNA) Synthetase (KARS) Mutations: The Expanding Phenotype of Aminoacyl-Transfer RNA Synthetase Mutations in Human Disease.
    McMillan HJ; Humphreys P; Smith A; Schwartzentruber J; Chakraborty P; Bulman DE; Beaulieu CL; ; Majewski J; Boycott KM; Geraghty MT
    J Child Neurol; 2015 Jul; 30(8):1037-43. PubMed ID: 25330800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases.
    Wei N; Zhang Q; Yang XL
    J Biol Chem; 2019 Apr; 294(14):5321-5339. PubMed ID: 30643024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy.
    Lee AJ; Nam DE; Choi YJ; Nam SH; Choi BO; Chung KW
    Genes Genomics; 2020 Jun; 42(6):663-672. PubMed ID: 32314272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four pedigrees with aminoacyl-tRNA synthetase abnormalities.
    Okamoto N; Miya F; Tsunoda T; Kanemura Y; Saitoh S; Kato M; Yanagi K; Kaname T; Kosaki K
    Neurol Sci; 2022 Apr; 43(4):2765-2774. PubMed ID: 34585293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMT disease severity correlates with mutation-induced open conformation of histidyl-tRNA synthetase, not aminoacylation loss, in patient cells.
    Blocquel D; Sun L; Matuszek Z; Li S; Weber T; Kuhle B; Kooi G; Wei N; Baets J; Pan T; Schimmel P; Yang XL
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19440-19448. PubMed ID: 31501329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation.
    Oprescu SN; Chepa-Lotrea X; Takase R; Golas G; Markello TC; Adams DR; Toro C; Gropman AL; Hou YM; Malicdan MCV; Gahl WA; Tifft CJ; Antonellis A
    Hum Mutat; 2017 Oct; 38(10):1412-1420. PubMed ID: 28675565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.
    Oprescu SN; Griffin LB; Beg AA; Antonellis A
    Methods; 2017 Jan; 113():139-151. PubMed ID: 27876679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.